Niall O’Connor is a technology leader in the healthcare and life sciences spaces. Currently, Niall serves as the Chief Technology Officer for Cohere Health.
Prior to joining Cohere, Niall acted as Chief Technology Officer for Genospace, a cloud-based software company focused on delivering personalized medicine. Niall was a member of the founding team at Genospace which was acquired by Sarah Cannon, the Cancer Institute of HCA. Niall also held software engineering positions at Dana-Farber Cancer Institute and Fidelity Investments.
Niall earned a B.E. in Electronics and Computers from the National University of Ireland, Galway, and attended the Executive Education Program at the Wharton School of the University of Pennsylvania.